These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 15127425)

  • 1. Why cost-effectiveness should trump (clinical) effectiveness: the ethical economics of the South West quadrant.
    Dowie J
    Health Econ; 2004 May; 13(5):453-9. PubMed ID: 15127425
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Kinky thresholds revisited: opportunity costs differ in the NE and SW quadrants.
    Eckermann S
    Appl Health Econ Health Policy; 2015 Feb; 13(1):7-13. PubMed ID: 25362257
    [TBL] [Abstract][Full Text] [Related]  

  • 3.
    Dowie J; Kaltoft MK; Nielsen JB; Salkeld G
    F1000Res; 2015; 4():1078. PubMed ID: 27803795
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Is there a kink in consumers' threshold value for cost-effectiveness in health care?
    O'Brien BJ; Gertsen K; Willan AR; Faulkner LA
    Health Econ; 2002 Mar; 11(2):175-80. PubMed ID: 11921315
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Variability of cost-effectiveness estimates for pharmaceuticals in Western Europe: lessons for inferring generalizability.
    Barbieri M; Drummond M; Willke R; Chancellor J; Jolain B; Towse A
    Value Health; 2005; 8(1):10-23. PubMed ID: 15841890
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Does NICE have a cost-effectiveness threshold and what other factors influence its decisions? A binary choice analysis.
    Devlin N; Parkin D
    Health Econ; 2004 May; 13(5):437-52. PubMed ID: 15127424
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Incremental cost-effectiveness of adult spinal deformity surgery: observed quality-adjusted life years with surgery compared with predicted quality-adjusted life years without surgery.
    McCarthy I; O'Brien M; Ames C; Robinson C; Errico T; Polly DW; Hostin R;
    Neurosurg Focus; 2014 May; 36(5):E3. PubMed ID: 24785485
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cost-effectiveness of group psychotherapy for depression in Uganda.
    Siskind D; Baingana F; Kim J
    J Ment Health Policy Econ; 2008 Sep; 11(3):127-33. PubMed ID: 18806302
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cost-effectiveness acceptability curves and a reluctance to lose.
    Severens JL; Brunenberg DE; Fenwick EA; O'Brien B; Joore MA
    Pharmacoeconomics; 2005; 23(12):1207-14. PubMed ID: 16336015
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Incremental cost effectiveness evaluation in clinical research.
    Krummenauer F; Landwehr I
    Eur J Med Res; 2005 Jan; 10(1):18-22. PubMed ID: 15737949
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Using threshold values for cost per quality-adjusted life-year gained in healthcare decisions.
    Cleemput I; Neyt M; Thiry N; De Laet C; Leys M
    Int J Technol Assess Health Care; 2011 Jan; 27(1):71-6. PubMed ID: 21262069
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cost-effectiveness of endovascular repair, open repair, and conservative management of splenic artery aneurysms.
    Hogendoorn W; Lavida A; Hunink MG; Moll FL; Geroulakos G; Muhs BE; Sumpio BE
    J Vasc Surg; 2015 Jun; 61(6):1432-40. PubMed ID: 25827968
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acceptance and rejection: cost-effectiveness and the working nephrologist.
    McFarlane PA; Bayoumi AM
    Kidney Int; 2004 Nov; 66(5):1735-41. PubMed ID: 15496144
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cost-utility analysis of a treatment advice to discontinue inappropriate long-term antidepressant use in primary care.
    Eveleigh R; Grutters J; Muskens E; Oude Voshaar R; van Weel C; Speckens A; Lucassen P
    Fam Pract; 2014 Oct; 31(5):578-84. PubMed ID: 25121977
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Incremental cost-effectiveness ratios (ICERs): the silence of the lambda.
    Gafni A; Birch S
    Soc Sci Med; 2006 May; 62(9):2091-100. PubMed ID: 16325975
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Eliciting stated preferences for health-technology adoption criteria using paired comparisons and recommendation judgments.
    Johnson FR; Backhouse M
    Value Health; 2006; 9(5):303-11. PubMed ID: 16961548
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The augmented representation of the cost-effectiveness acceptability curve for economic evaluation of health technology.
    Araki D; Kamae I
    Kobe J Med Sci; 2015 Mar; 61(1):E9-18. PubMed ID: 25868612
    [TBL] [Abstract][Full Text] [Related]  

  • 18. When is enough evidence enough? - Using systematic decision analysis and value-of-information analysis to determine the need for further evidence.
    Siebert U; Rochau U; Claxton K
    Z Evid Fortbild Qual Gesundhwes; 2013; 107(9-10):575-84. PubMed ID: 24315327
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cost effectiveness of telehealth for patients with long term conditions (Whole Systems Demonstrator telehealth questionnaire study): nested economic evaluation in a pragmatic, cluster randomised controlled trial.
    Henderson C; Knapp M; Fernández JL; Beecham J; Hirani SP; Cartwright M; Rixon L; Beynon M; Rogers A; Bower P; Doll H; Fitzpatrick R; Steventon A; Bardsley M; Hendy J; Newman SP;
    BMJ; 2013 Mar; 346():f1035. PubMed ID: 23520339
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cost-Effectiveness of Bariatric Surgery Prior to Total Knee Arthroplasty in the Morbidly Obese: A Computer Model-Based Evaluation.
    McLawhorn AS; Southren D; Wang YC; Marx RG; Dodwell ER
    J Bone Joint Surg Am; 2016 Jan; 98(2):e6. PubMed ID: 26791039
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.